Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Leyvraz

Showing results (41-50 of 108) with videos related to

Pageof 11
Sort By:
Helvetica Chirurgica Acta|December 1, 1989
[Epidermoid carcinoma of the esophagus: preliminary results of combined treatment]M Merlini, S Gabellon, W Elbaze, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)S Leyvraz, M Bacchi, T Cerny, et al.
Progress in Clinical and Biological Research|January 1, 1987
Clonogenic and functional potential of T lymphocytes infiltrating human solid tumorsV von Fliedner, L Qiao, T L Whiteside, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
The Family System Test (FAST). A pilot study in families with a young adult member with cancerReal del Sartre, F Stiefel, S Leyvraz, et al.
Cancer Investigation|January 1, 1993
Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II studyB Chevallier, S Leyvraz, J P Olivier, et al.
British Journal of Cancer|February 25, 2010
Imatinib plasma levels: correlation with clinical benefit in GIST patientsN Widmer, L A Decosterd, C Csajka, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Treatment of bone metastases from breast cancer and myeloma with pamidronateD Thiébaud, S Leyvraz, V von Fliedner, et al.
Journal of the National Cancer Institute|May 20, 1992
Pharmacokinetics of pamidronate in patients with bone metastasesS Leyvraz, U Hess, G Flesch, et al.
Oncology|October 13, 2001
Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbineR Stupp, A Bodmer, B Duvoisin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanomaB Gerard, S Aamdal, S M Lee, et al.
Pageof 11

Showing results (41-50 of 108) with videos related to

Sort By:
Pageof 11
Helvetica Chirurgica Acta|December 1, 1989
[Epidermoid carcinoma of the esophagus: preliminary results of combined treatment]M Merlini, S Gabellon, W Elbaze, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 1998
Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas. Swiss Group for Clinical Research (SAKK)S Leyvraz, M Bacchi, T Cerny, et al.
Progress in Clinical and Biological Research|January 1, 1987
Clonogenic and functional potential of T lymphocytes infiltrating human solid tumorsV von Fliedner, L Qiao, T L Whiteside, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 8, 1998
The Family System Test (FAST). A pilot study in families with a young adult member with cancerReal del Sartre, F Stiefel, S Leyvraz, et al.
Cancer Investigation|January 1, 1993
Epirubicin and ifosfamide in advanced soft tissue sarcoma: a phase II studyB Chevallier, S Leyvraz, J P Olivier, et al.
British Journal of Cancer|February 25, 2010
Imatinib plasma levels: correlation with clinical benefit in GIST patientsN Widmer, L A Decosterd, C Csajka, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Treatment of bone metastases from breast cancer and myeloma with pamidronateD Thiébaud, S Leyvraz, V von Fliedner, et al.
Journal of the National Cancer Institute|May 20, 1992
Pharmacokinetics of pamidronate in patients with bone metastasesS Leyvraz, U Hess, G Flesch, et al.
Oncology|October 13, 2001
Is cisplatin required for the treatment of non-small-cell lung cancer? Experience and preliminary results of a phase I/II trial with topotecan and vinorelbineR Stupp, A Bodmer, B Duvoisin, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Activity and unexpected lung toxicity of the sequential administration of two alkylating agents--dacarbazine and fotemustine--in patients with melanomaB Gerard, S Aamdal, S M Lee, et al.
Pageof 11